Skip to main content
. Author manuscript; available in PMC: 2010 Oct 11.
Published in final edited form as: Transplantation. 1995 Feb 27;59(4):485–490. doi: 10.1097/00007890-199559040-00007

TABLE 1.

One year actual graft survival

2-Drug 3-Drug Total 2 vs. 3 Subgroup
Overall 92% 82% 87% P < .02
1st Cadaveric 90% 87% 88% NS
1st Transplant 90% 87% 89% NS NS
Retransplantation 97% 72% 84% P < .02
Cadaveric 92% 82% 87% P < .03 NS
Living-donor 94% 88% 92% NS
PRA <40% 91% 84% 87% NS NS
PRA >40% 100% 77% 86% P < .04
Adult kidneys 93% 83% 88% P < .02 NS
En bloc 80% 79% 79% NS
No ATN 100% 88% 93% P < .001 P < .0001
ATN 81% 71% 77% NS
Rejection 91% 76% 85% P < .03 NS
No rejection 94% 87% 90% NS
Donors >60 years 77% 80% 78% NS NS
Donors <60 years 94% 83% 88% P < .02
Black 92% 87% 89% NS NS
Nonblack 92% 82% 87% P < .02
Recipients <60 years 93% 83% 88% P < .02 NS
Recipients >60 years 82% 82% 82% NS